Take the next step!  

Advanced Workshop II in Ketamine and Psychedelic Assisted Therapies

Advanced Workshop II in Ketamine and Psychedelic Assisted Therapies

 
$0.00

Series
Select...
Certificate
Select...
Over 15,000 students taught
Psychedelic Support has enrolled over 15,000 students in our free and paid courses! All proceeds from our paid courses have gone into funding more education and resources for the public around safe and ethical use of psychedelics in therapy and harm reduction.
Training Description

Join Polaris Insight Center for an advanced workshop where we continue to explore major themes in ketamine- and psychedelic-assisted therapy from prior modules, in order to support clinicians in improving both the quality of their clinical work as well as their own self-care.

We focus on additional special topics in the application of principles and practices of psychedelic-assisted psychotherapies as they relate to the topics of neurotheology (the intersection of spiritual practices and neurophysiology); ketamine and mystical experiences; the relationship between meditation, psychedelics, self-care and improved preparation phase interventions; and the dynamics of the therapy relationship with a particular emphasis on both the intersection of working with symbols and images and subtle intuition within a relational psychoanalytic theoretical perspective and approaches.

Teachings are appropriate for healthcare professionals as well as the general public. Healthcare professionals will be able to incorporate the tools and practices offered in this program in ways beneficial to clients or patients.

Polaris offers modules 1 to 5 ketamine therapy training series. Module 7 can be taken without completing the prior modules.

All modules are taught live online through Zoom. Earn 8 hours of continuing education (CE).

Training Curriculum

Module 7 - Advanced Workshop II on Ketamine- and Psychedelic-Assisted Psychotherapies Live/Online 


In this module, we continue the exploration of major themes in ketamine- and psychedelic- assisted therapy from prior modules, to support clinicians in improving both the quality of their clinical work, theoretical understanding, as well as their own self-care.

We focus on additional special topics in the application of principles and practices of psychedelic-assisted psychotherapies as they relate to the topics of: understanding neurotheology (the intersection of spiritual practices and neurophysiology); understanding ketamine and mystical experiences; the relationship between meditation, psychedelics, self- care and improved preparation phase interventions; a review of early research on subjective experiences of ketamine; a survey and review of the topic of religious and spiritual trauma and its relationship to ketamine and other psychedelic-assisted psychotherapies; and, an innovative approach to the issue of integration from an eco-psychedelic point of view.

 

Teachings are appropriate for healthcare professionals as well as the general public. Healthcare professionals will be able to incorporate the tools and practices offered in this program in ways beneficial to clients or patients.

 

Module 7 Learning Objectives

 

  1. After completing this module, participants will be able to:
  2. Describe the range of experiences a patient could have with IM ketamine.
  3. Demonstrate 2 ways of using nature-based practices to support integration.
  4. List three types of spiritual trauma that are likely to appear in KAP and other psychedelic-assisted therapy sessions.
  5. Explain the difference between religious and spiritual trauma.
  6. List and describe two meditative practices that can be used for helping with therapist and patient attunement and therapist self-care in psychedelic assisted psychotherapy.
  7. Describe two important areas of research in the emerging field of neurotheology.
Meet your Training Instructors:
Harvey Schwartz, PhD
Harvey is a licensed psychologist who specializes in treating complex PTSD, dissociative disorders, as well as patients with spiritual and therapy-related trauma. He has undergone advanced Ketamine-Assisted Therapy training through the Ketamine Training Center and the MAPS MDMA-Assisted Therapy Training Program and is currently a Sub-Investigator and Co-therapist, a supervisor and a trainer on the MAPS MDMA-Assisted Therapy Clinical Trials. In his clinical work and consultation, he synthesizes relational psychodynamic, archetypal, existential, and mindfulness perspectives. He has worked on advancing the theory and practice of integration in psychedelic therapies. Harvey is the training director and a lead trainer in the Polaris Insight Training Program.
Harvey Schwartz, PhD
Psychologist
Polaris Insight Center
Steve Rosonke, MD
Steve Rosonke MD is an ER physician and addiction medicine physician. He is also fellowship-trained in critical care. He has been administering ketamine in a variety of clinical settings since 2001. In 2018, he founded Rainfall Medicine, a ketamine center in Portland, OR where he treats mood disorders, trauma, chronic pain, end-of-life anxiety, and addiction. He has also been teaching and consulting other providers on this topic.
Steve Rosonke, MD
Physician
Rainfall Medicine
Keith Lowenstein, MD
Board certified in psychiatry, obesity and integrative medicine, Dr. Keith Lowenstein works with children, adolescents, adults and families with a focus on stress-related illness, both mental and physical. With more than 25 years of clinical experience in psychiatry, nutrition, integrative holistic medicine and alternative therapies, he has a lifelong commitment to a comprehensive approach to human health and development. He has been providing instruction in Kriya yoga meditation since 1980 and spent approximately 5 years living with and learning from Ganesh Baba.
Keith Lowenstein, MD
Psychiatrist
Private Practice
George Greer, MD
Dr. Greer conducted over 100 therapeutic sessions with MDMA for 80 individuals from 1980 to 1985, and 35+ sessions with ketamine with his psychiatric nurse wife, Requa Tolbert. He is a Distinguished Life Fellow of the American Psychiatric Association and Past President of the Psychiatric Medical Association of New Mexico. He was the Medical Director of the Heffter Research Institute from 1998 to 2021 and is the current Board Chair.
George Greer, MD
Psychiatrist
Heffter Research Institute
Emily Willow, MD
Emily Willow, MD is a board-certified psychiatrist, researcher, and educator based in San Francisco, California. She is an ardent advocate for psychedelic medicine and has worked on multiple clinical trials investigating psychedelic-assisted psychotherapy – including both MDMA and psilocybin. Dr Willow has a private practice in San Francisco, CA where she focuses on ketamine assisted psychotherapy, psychedelic integration and climate mental health. In addition, her clinical work extends to Zuckerberg SF General Hospital in Psychiatric Emergency Services as an attending psychiatrist through the University of California, San Francisco.  She has held multiple mentorship and teaching roles including at the California Institute of Integral Studies in the Center for Psychedelic Therapies and Research and the School of Consciousness and Transformation.
Emily Willow, MD
Psychiatrist
Private Practice
Extra Info

All modules are taught live online through Zoom. Earn 16 hours of continuing education (CE) - select CE option.

 

Module 7 Upcoming Dates:

  • Friday August 16, 2024 at 9 am - 5 pm Pacific Time

 

Target Audience:
This course is designed for mental health professionals – MDs, DOs, NDs, NPs, RNs, PsyDs, PhDs, LMFTs, LCSWs, LPCs, LEPs. Open to the public.

 

Accommodations:
To request accommodations for special needs, please email the program administrator at training@polarisinsight.com

 

Cancellation Policy:
Participants need to cancel up to 2 weeks in advance to receive a 100% refund (minus a $25 admin fee and payment processing fee). If cancelled after the 2-weeks-in-advance period they can use the credit for a future training or receive 50% refund (minus a $25 admin fee and payment processing fee).